Israel Prepares For Clash With U.S., E.U. Over Drug Patent Policy
The cabinet’s intention to approve a proposed change in protection for intellectual property rights of international pharmaceutical companies threatens “a crisis in U.S.-Israel trade relations,” financial daily Globes reported.
The proposal under consideration does not meet the demands of U.S. Trade Representative Robert Zoellick, who has threatened to put Israel back on the "priority...
To view the full article, register now.